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Background: Although cigarette smoke is known to be a complex mixture of over 4000 substances that
can lead to damage through active or passive smoking, its mechanisms and biochemical consequences in
pregnancy and neonates are not yet fully understood. Therefore, in the present study, we propose to study
the impact of smoking during gestation on the viability of blood mononuclear cells (MNC) from umbilical
cords of newborns to assess the degree of oxidative stress and cell viability. After childbirth, the cord blood and the
umbilical cord were immediately collected in public hospitals in Greater Vitoria, ES, Brazil. Flow cytometry was used to
analyze the cord blood followed by biochemical and histological tests to analyze possible changes in the umbilical
cord.
Results: Pregnant smokers had a reduction of MNC viability from the umbilical cord (10%), an increase in
the production of reactive oxygen species (ROS) and an increase in cell apoptosis (~2-fold) compared to
pregnant non-smokers. In the umbilical cord, it was observed an increase of advanced oxidation protein
products - AOPP (~2.5-fold) and a loss of the typical architecture and disposition of endothelial cells from
the umbilical artery.
Conclusions: These data suggest that maternal cigarette smoking during pregnancy (even in small amounts)
may compromise the viability of MNC cells and damage the umbilical cord structure, possibly by excessive ROS
bioavailability.
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Maternal smoking has been considered the most import-
ant modifiable risk factor associated with adverse preg-
nancy outcomes [1,2]. Moreover, recent epidemiological
data show that almost 20–30% of women continues to
smoke during pregnancy [3,4]. This behavior causes im-
portant metabolic and biochemical changes and adaptive
responses in both the fetus and the mother, resulting in* Correspondence: pereiratmc@gmail.com
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unless otherwise stated.an increased incidence of complications such as spontan-
eous abortion, placental abruption, preterm delivery, intra-
uterine growth restriction and stillbirth [5,6]. Although
there is evidence that several tobacco metabolites can
cross the placental barrier and cause both perinatal and
postnatal health consequences [7-9], the causal relation-
ship between exposure to smoking and increase in human
cellular injury is not yet clearly understood [10] because
the human materno-fetal tissues exposed to cigarette
smoking remain poorly studied [11].
It has become evident that oxidative stress is one of
the most important mechanisms involved in tobacco
smoking during pregnancy [6,10,12,13]. The increase in
reactive oxygen species (ROS) production from exogen-
ous and endogenous sources results in an imbalanceis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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dant defenses [14-16]. Consequently, ROS in fetal struc-
tures may modify the activation of a complex array of
genes involved in cell cycle signal transduction and
homeostasis control, contributing to defects in endogen-
ous stem cell repair mechanisms [17] and consequently,
development of many diseases [10,18,19].
Our laboratory has evaluated ROS production by
flow cytometry and biochemical analysis to under-
stand oxidative stress-related diseases using experi-
mental models of atherosclerosis and hypertension
[16,20,21]. Therefore, it seems reasonable to use these
approaches to evaluate materno-fetal tissues damaged
by superoxide anion (•O2
−) and hydrogen peroxide
(H2O2) or to evaluate the oxidative damage to DNA or
proteins due to exposure of the fetus to smoking.
Therefore, the aim of the present study was to evaluate
the molecular, cellular and histological parameters that
might be altered in pregnant mothers and fetuses due to
maternal cigarette smoking. We hypothesize that mater-
nal smoking might impair the viability of umbilical cord
mononuclear blood cells (MNC) and might lead to fur-
ther injury of other tissues such us the umbilical cord,
possibly mediated by oxidative stress.Methods
Patients
We recruited healthy pregnant women who were admit-
ted to the Hospitals and Clinics of the Greater Vitória
(Vitória, Vila Velha and Serra, Brazil) and who voluntar-
ily provided written informed consent in a form that was
previously approved by the Brazilian Ethical Committee
for human research ‘Plataforma Brasil’ (n° 065700120
00005064, 12/12/2012). Exclusion criteria were: age less
than 18 years, gestational age less than 37 weeks, fetal dis-
tress (Apgar score <7 at first minute), previous infection
or inflammatory conditions, amniorrhexis more than
18 hours previously and presence of infectious or inflam-
matory processes during pregnancy or disorders such as
cardiovascular and/or renal diseases, diabetes mellitus and
pre-eclampsia. Gestational age was determined by the last
menstrual period and confirmed by the Capurro index
after birth. None of the fetuses showed an abnormality.
All subjects were of similar socio-economic status and
lived in urban areas. The study population consisted of 69
healthy pregnant women. At the first visit, a history of
smoking was obtained by directly questioning the preg-
nant women. Smokers were defined as women who self-
reported a maintained smoking habit of at least one
cigarette per day during pregnancy (median: 6; range: 1–
20). Non-smokers were defined as women who had never
smoked and were not exposed to environmental tobacco
smoke during their current pregnancies.Blood and umbilical cord samples
Mixed venous and arterial umbilical cord blood was ob-
tained immediately postpartum from the umbilical vein
after clamping the cord. EDTA blood samples were
stored at 4°C until flow cytometry analysis. Immediately
after cord blood collection, each umbilical cord was di-
vided into two sections, proximal and distal portions of
the placenta, which were stored at −196°C and at 4°C,
respectively, in 10% (w/v) formaldehyde.
Cell samples and viability assay for flow cytometry
Blood samples were homogenized and mixed with
Dulbecco's Modified Eagle Medium (DMEM) to nour-
ish the cells. The homogenate was then loaded onto a
Ficoll-Paque™ PLUS (GE Healthcare, Waukesha, WI)
gradient. The layer containing mononuclear cells
(MNCs) was removed, washed thrice with PBS and re-
suspended for flow cytometry analysis. Cell viability
was assessed by propidium iodide (PI) staining exclu-
sion. A total of 106 cells were incubated with 2 μL of
PI for 5 min in the dark at room temperature. The
cells were washed with PBS and analyzed with a
FACS-Canto II flow cytometer (Becton Dickinson, San
Jose, CA, USA). For viability quantification, samples
were acquired in triplicate, and 10,000 events were used
for each measurement. Cells were excited with a wave-
length of 488 nm, and PI fluorescence was detected using
a 585/42 bandpass filter. Data are expressed as the per-
centage of unstained/viable cells [21].
Measurement of intracellular reactive oxygen species and
apoptosis
ROS was analyzed in umbilical cord blood cells by flow
cytometry as previously described [21-23]. Dihydroethi-
dium (DHE) and 2′,7′-dichlorofluorescein diacetate
(DCF) were used to detect intracellular •O2
− and H2O2,
respectively. Given its ability to freely permeate cell mem-
branes, DHE has extensively been used to monitor •O2
−
production. Upon reaction with •O2
−, DHE is rapidly oxi-
dized to form ethidium bromide, a red fluorescent product
that intercalates between the base pairs of DNA and amp-
lifies the red fluorescence signal. DCF is a cell-permeant
indicator of H2O2 production that is nonfluorescent until
oxidation occurs within the cell, converting DCF-DA into
its fluorescent form, which remains trapped in the cell.
DHE (160 µM) and DCF (20 mM) were added to cell sus-
pensions (106 cells), which were then incubated at 37°C
for 30 min in the dark to determine the intracellular •O2
−
and H2O2 concentrations, respectively [16]. Human sam-
ples that were treated with 10 μM doxorubicin or 50 mM
H2O2 for 5 min to create oxidative stress without cell
toxicity were used as the positive control. Cells were
washed, resuspended in PBS and maintained on ice for
immediate detection by flow cytometry (FACSCanto II,
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lyzed using the FACSDiva software (Becton Dickinson),
and overlay histograms were constructed using the FCS
Express software. For fluorescence quantification, samples
were acquired in duplicate, and 10,000 events were used
for each measurement. Cells were excited with a wave-
length of 488 nm, and DHE and DCF were detected using
a 585/42 bandpass filter (DHE) and a 530/30 bandpass fil-
ter (DCF).
Apoptotic cells were quantified by Annexin V-FITC and
Propidium iodide (PI) double staining, using an Annexin
V-FITC apoptosis detection kit (Becton Dickinson, San
Jose, CA, USA). In brief, cord blood-derived cells were
washed twice with PBS and adjusted to 500 μL of the
binding buffer (5 × 105 cells). Then, 2 μl of Annexin
V–FITC and 2 μl of PI were added, and the cells were
gently vortexed. Cells were incubated for 15 min at
room temperature (25°C) in the dark. Finally, cells were
analyzed by the flow cytometer FACSCanto II (Becton
Dickinson). Annexin V-/PI+ cells were recognized as un-
viable, Annexin V+/PI+ were considered to be in late
apoptosis or necrosis and Annexin V+/PI- cells were rec-
ognized as early or primary apoptotic cells [24].
AOPP determination
Dityrosine-containing protein cross-linking products or
advanced oxidation protein products designated as
AOPP, are the products of HOCl-induced chlorination
of amines. AOPP were measured according to the
method described by Witko-Sarsat et al. [25] using spec-
trophotometry with a microplate reader. Two hundred
microliters of homogenate of human umbilical cord
diluted 1:5 in PBS, or chloramine-T standard solutions
(0 to 100 μM), were placed in each well of a 96-well mi-
crotiter plate (Becton Dickinson Labware, Lincoln Park,
NJ, USA). 10 μL of 1.16 M potassium iodide (KI, Sigma)
was added, followed by the addition of 20 μL of acetic
acid. The absorbance of the reaction mixture was imme-
diately read at 340 nm in a microplate reader against a
blank containing 200 μl of PBS, 10 μL of KI and 20 μL
of acetic acid. The chloramine-T absorbance at 340 nm
was linear within the range of 0 to 100 μM. AOPP
was determined when the correlation coefficient was
greater than 0.95. The concentrations were expressed
in μmol/mg of total protein, previously quantified by
the Bradford method [26], in which samples were di-
luted 1:10 for dosage.
Vessel processing and morphology
The umbilical cord samples of non-smokers (n = 10) and
smokers (n = 12) were paraffin embedded, sectioned
transversely (8 μm thick) and stained with hematoxylin-
eosin for detection of cellularity and vascular thickness.
The portion chosen was the cord halfway between theplacental and fetal insertion, avoiding any areas showing
physical abnormality. Images of the vein and arteries
form the umbilical cord were captured with a color
video camera (AxioCam ERc 5 s, Carl Zeiss, Germany)
connected to a microscope (Olympus AX70, Olympus,
Center Valley, PA, USA). Analysis was conducted with a
Zeiss image processing software (AxioVision) by an
examiner blinded to the experimental groups. The pro-
gram was calibrated with a graduated slide. Using a 4×
objective, the vessel cross-sectional area (VCSA) and the
lumen cross-sectional area were calculated. The vessel
and lumen cross sectional areas were compared between
the smoking group and the non-smoking group.
Scanning electron microscopy (SEM)
Proximal umbilical cord samples were fixed in parafor-
maldehyde (2%)-glutaraldehyde (2,5%) cacodylate buffer
solution (0.1 M; pH 7.2) for 24 h, washed with cacody-
late buffer, postfixed in a solution of 2.5% potassium
ferrocyanide for 1 h, and washed again in cacodylate
buffer and ultrapure water. Stereomicroscopy was used
to obtain longitudinal sections of vessels from the um-
bilical cord samples. Sections were dehydrated in as-
cending grades of ethanol, subjected to critical point
drying in CO2 (Autosandri-815, Tousimis), coated with
10 nm of pure gold in a vacuum sputter coater (Desk V,
Denton Vacuum) and studied in a direct mode using a
scanning electron microscope (Jeol, JEM6610 LV).
Statistical analysis
All data are expressed as the mean ± SEM. The statistical
analysis was performed using Student’s t-test for inde-
pendent samples. The statistical analyses were performed
using Prism software (Prism 6, GraphPad Software, Inc.,




Table 1 shows the clinical characteristics of mothers and
newborns. There were no significant differences between
the smoking and non-smoking groups in physical exami-
nations, anthropometric measurements and/or conven-
tional hematological parameters analyzed. However, we
observed a remarkable decrease in the viability of blood
cells of umbilical cord blood in the smokers group (86 ±
2.0%) compared to the non-smokers group (95 ± 1.1%,
p <0.05.)
Reactive oxygen species (ROS) and apoptosis in blood
cells of umbilical cord blood
ROS production was assessed using flow cytometry with
DHE and DCF to quantify the production of •O2
− and
H2O2, respectively, which are reported as geometric





Age 25.8 ± 1 26.6 ± 0.9
Number of cigarettes per day none 8.5 ± 1.1
Mean arterial pressure (mmHg) 81 ± 1.3 84 ± 1.5
Gestational age 39.8 ± 0.3 39.3 ± 0.3
Capurro index 39.8 ± 0.14 39.6 ± 0.14
Delivery
Vaginal delivery 18/38 (47%) 27/31 (87%)
Cesarean section 20/38 (53%) 4/31 (13%)
Birth weight (g) 3248 ± 83 3030 ± 80
Apgar score (median and range) 1 min 9 (8–9) 9 (8–9)
5 min 10 (9–10) 10 (9–10)
Cephalic perimeter (cm) 33.8 ± 0.15 33.5 ± 0.16
Maternal hematocrit (%) 35.1 ± 0.53 34.5 ± 0.46
Maternal hemoglobin (g/dL) 11.8 ± 0.15 11.5 ± 0.15
Viability of umbilical cord mononuclear
blood cells (%)
95 ± 1.1 86 ± 2.0*
The values are presented as means ± SEM. *p < 0.05 vs. non-smoking patients.
Figure 1 Reactive oxygen species (ROS) production. (A) Representative
(DHE) and 2',7'-dichlorofluorescein (DCF) in umbilical cord mononuclear blo
illustrates the intensity of fluorescence for the number of cells counted. (B)
anions (by DHE) and hydrogen peroxide (by DCF) in the smokers group (n
non-smokers group (n = 30).
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gram from flow cytometry analysis show a rightward-shift
in the log of DHE and DCF fluorescence in the smokers
group (Figure 1A) compared with the non-smokers group.
As expected, in Figure 1B we observed a remarkable in-
crease in the levels of ROS production in the smokers
group (DHE: 1887 ± 189; DCF: 814 ± 66 a.u.) compared to
the non-smokers group (DHE: 987 ± 71 and DCF: 532 ±
27 a.u., p <0.05). Apoptosis in the same cells was evaluated
by flow cytometry using FITC-annexin V and PI. Figure 2
shows representative dot plots for each group. A remark-
able increase in apoptotic cell number (Q2 +Q4) was ob-
served in the smokers group (38 ± 4.5%) compared to the
non-smokers group (19 ± 3.7%, p <0.05).AOPP determination in the umbilical cord
To estimate the degree of oxidant-mediated protein
damage in the umbilical cord, the presence of AOPP
was investigated. As shown in Figure 3, AOPP levels
were significantly increased (p <0.05) in the smokers
group compared to the non-smokers group (232 ± 53 vs.
93 ± 14 μmol/mg protein, respectively).histograms from flow cytometry analysis using dihydroethidium
od cells from non-smokers and smokers. The log fluorescence (X-axis)
Bar graph showing a remarkable increase in the level of superoxide
= 23). The values are presented as means ± SEM. *p < 0.05 vs.
Figure 2 Flow cytometry analysis of apoptosis. Dot plots show apoptosis ratios of umbilical cord mononuclear blood cells from (A) non-smokers
(n = 13, left panel) and smokers (n = 13, right panel) using propidium iodide (PI) and FITC-annexin V. The Q1 quadrant represents unviable cells
(PI positive and annexin negative). The Q2 quadrant represents cell that are in late apoptosis or necrosis (both annexin and PI positive). The Q3
quadrant represents viable cells (both annexin and PI negative). The Q4 quadrant represents cells in early apoptosis/cell apoptosis (annexin positive
and PI negative). Note the remarkable increase in apoptotic cells number (Q2 + Q4) in the smokers group (n = 13). (B) Bar graph shows average
percentage of apoptotic cells (Q2 + Q4). The values are presented as means ± SEM. *p <0.05 vs. non-smokers.
Rua et al. Journal of Biomedical Science  (2014) 21:105 Page 5 of 9Histological examinations
Figure 4 summarizes the data of the cross sectional area
of the umbilical cord vessels, showing a similar lumen
area in the smokers and non-smokers groups, both in
veins (37.5 ± 4.5 vs. 33.8 ± 4.9%, respectively) and arteries
(7.3 ± 0.96 vs. 6.1 ± 0.92%, respectively). Moreover, weFigure 3 AOPP quantification. Levels of advanced oxidation
protein products (AOPP) in umbilical cord blood from pregnant
non-smokers (n = 6) and smokers (n = 8). The values are presented
as means ± SEM. *p <0.05 vs. non-smokers.did not find significant modification of vessel total area
(data not shown), indicating absence of outward vascular
remodeling. Figure 5 shows typical photomicrographs of
scanning electron microscopy (SEM) of vascular endo-
thelium from umbilical arteries of pregnant patients,
exhibiting diffuse areas of endothelial thickening withFigure 4 Lumen area analysis. Bar graphs showing percentage of
cross-sectional luminal areas of arteries (white bars) and veins (black
bars) from the umbilical cord of the non-smokers group (n = 10) and
the smokers group (n = 12). The values are presented as means ± SEM.
Figure 5 Scanning electron microscope (SEM) photographs of the vascular endothelium from umbilical arteries of pregnant patients.
A) A typical image from a non-smoking patient shows a regular surface accompanying the longitudinal direction of the vessel. B) A typical image
from a smoking patient shows diffuse areas of endothelial thickening with loss of the typical architecture and disposition of endothelial cells
(white arrows). Scale bar: 10 µm.
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thelial cells in the smokers group.
Discussion
Cumulative evidence shows that cigarettes may be the
single most significant source of toxic chemical exposure
and chemically mediated illness in humans, and that
maternal smoke exposure in pregnancy can cause sub-
stantial harm to women and their developing fetuses
[27-29]. However, the causal relationship between expos-
ure to smoke and increase in human cellular injury has
not yet been clearly demonstrated [10]. Therefore, it is
important to determinate the impact and etiology of
tobacco-related effects on the maternal-fetal interface
throughout pregnancy. In the present study, we report
for the first time that exposure to cigarette smoke may
compromise the cell viability of MNC and damage the
umbilical cord structure, possibly mediated by oxidative
stress.
In the present study, we evaluated two groups of pa-
tients with similar characteristics appropriate for normal
gestational age who had not been exposed to any adverse
events (other than cigarette smoke, for the one group).
Our results on cigarette smoke exposure highlight two
important findings: First, the biochemical and structural
alterations observed were not changed by previous fac-
tors intrinsic to smokers (e.g., malnutrition, anemia or
arterial hypertension). Second, our data revealed that
smoking (even in small amounts) may compromise the
neonate in parameters not conventionally analyzed in
previous clinical studies, such as impaired umbilical cord
blood MNC viability.
We have previously demonstrated the applicability of
flow cytometry with DHE and DCF to evaluate the pro-
duction of principal ROS (•O2
− and H2O2) in mouse
models of various diseases [16,20,21,23]. In this study,
we extended this analysis to human tissues by using flow
cytometry and found a higher level of ROS production
in umbilical cord blood MNC from smoking patients.This finding could indicate that macromolecular dam-
ages might occur in parallel by modifying intracellular
calcium homeostasis and several metabolic pathways
leading to apoptotic cell death, which has been shown in
other ROS-related diseases [16,18,21]. The annexinV/
propidium iodide staining approach allowed us to con-
firm our hypothesis of increased apoptosis of umbilical
cord blood MNC from smoking patients. Our finding
corroborates the idea from other research that there are
cellular impairments both in cord blood by gene expres-
sion profile [30] and in neonatal lymphocytes by cyto-
genetic analyses [4].
Although the apoptotic damage observed in MNC
might not accurately reflect similar injury in other tis-
sues, the early prejudice in this cell group could have an
important clinical applicability. First because MNC play
a central role in the development and repair of damaged
tissues throughout the life cycle, a compromise in MNC
might contribute to the early generation of many diseases
in childhood, including cancer [4,31], cardiovascular dis-
ease [32], respiratory disease [33], infectious disease [34]
and/or mental disease [35]. Second, the human umbilical
cord blood MNC, which contain hematopoietic, mesen-
chymal and endothelial stem cells [36], have a naive im-
munologic phenotype and a high regenerative potential,
making them a preferable choice for autologous trans-
plantation in recent therapeutic strategies for cancer
[37], neuroregeneration [38], hematopoietic disease [39]
and/or cardiovascular disease [40,41]. Therefore, our
data indicate that pregnancy-related factors such as ex-
posure to cigarette smoke may compromise the success
of cell therapy, in addition to technical approaches such
as cryopreservation or thawing [42,43].
We also found strong evidence of oxidative stress in
the umbilical cord of smoking patients by investigating
AOPP. Proteins are likely to be major targets of ROS, as
a result of their abundance in cells (approximately 70%
of the dry mass of most cells) and most tissues and their
rapid rates of reaction with many radicals and with other
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and basic amino acid residues, generating carbonyl moi-
eties, protein-protein cross-linkages, and oxidation of
the protein backbone, resulting in protein fragmentation
and loss in specific function [44]. An advantage of AOPP
analysis is due to the relatively long half-life of such
oxidized proteins [44], which can better demonstrate
the cumulative effect of oxidative stress. Moreover, the
AOPP remain stable during sample storage both at −20°C
and −80°C for 6 months [45], facilitating the subsequent
analysis of the collected samples, which are not collected
simultaneously. It should be noted that our data corrobor-
ate the data of several other groups that have successfully
demonstrated that AOPP is a potentially useful clinical
marker for the prediction of the stress/damage process
and age-related morphological and physiological distur-
bances [19,25,44,46].
Anatomopathological studies of umbilical cords and
placentas of newborn infants from mothers who are
smokers demonstrate that tobacco increases the release
of vasoactive substances and decreases the release of
vasodilator substances such as nitric oxide (NO) [47,48],
contributing further to oxidative stress, shear stress,
hypoxia and inflammation [13,49]. Based on a large
number of studies in animal models, these four types of
stimuli can drive a compensatory adaptive structural
change known as outward vascular remodeling [50-52].
Therefore, we analyzed whether the umbilical arteries
and/or vein developed this alteration. For the first time,
we have shown that this possible compensatory mechan-
ism does not appear to occur in the umbilical cords of
pregnant smokers.
The endothelium of umbilical blood vessels (both vein
and arteries) consists of a single layer of endothelial cells
whose cytoplasm is rich in mitochondria, the main
source of ROS [53]. While low levels of ROS are essen-
tial and participate in important intracellular signaling
pathways, excessive generation of ROS may result in
endothelial damage and plays a critical role in the pro-
gressive deterioration of vessel structure and function
[54,55]. Although this concept is well-established in ex-
perimental models [16,54] and in some classes of pa-
tients [56-58], few studies have been conducted in
newborns of cigarette smoking mothers [59,60]. In this
study, our data indicated an increase of the oxidative
stress biomarker AOPP in the umbilical cord and loss of
the typical architecture of endothelial cells in the same
tissue (by SEM analysis), providing further evidence of
ROS-mediated endothelial damage in neonatal passive
smokers. In bone marrow-derived MNC, there exists a
population of endothelial progenitor cells thought to
engage in endothelial repair that are considered potential
therapeutic agents in many pathological conditions [61,62].
Recent studies have reported that the disequilibriumbetween reparative endothelial cells and inflammatory leu-
kocytes may compromise the balance of vascular injury and
repair [16,61,63]. Our data are compatible with this hypoth-
esis, because the compromise of MNC in smoking mothers
could in part explain the impaired endothelial repair cap-
acity, thereby contributing to endothelial dysfunction.
A relative limitation of our study is that we did not
analyze these parameters with cotinine serum/urine/cord
blood determination. Cotinine has a longer half-life than
nicotine, and cotinine concentrations in serum, urine,
hair, and saliva are commonly used as biomarkers of re-
cent tobacco exposure in epidemiological studies [9,64].
There is most likely no placental barrier for plasma co-
tinine between pregnant mothers and their newborns.
Lack of a placental barrier for cotinine (and probably
nicotine) can partially explain smoking-related perinatal
disorders [4,9]. Therefore, combining the maternal self-
report of smoking with the level of urine cotinine con-
centration could improve the precision of the exposure
estimates [8,27,65].
Conclusions
These data show that maternal cigarette smoking during
pregnancy may compromise the viability of MNC and
damage the umbilical cord structure, possibly by excessive
ROS bioavailability. These results may provide a new
direction and alternative approach to investigations of the
impact of cigarette smoking during pregnancy.
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